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Differential response of neurotic symptoms
Jerzy A Sobański
SUMMARY
Aim: The paper reports symptom improvement during intensive psychotherapy in a day hospital at the 
Wojewódzki	Ośrodek	Leczenia	Nerwic.
Material: 3509 symptom checklists KO “0”, filled-in by 319 patients treated in day hospital in 1990–1998. 
The group consisted of 235 females and 84 males, with diagnoses of somatization disorder, generalised 
anxiety disorder, dissociative motor and sensory disorders and with comorbid diagnoses.
Method: Symptom checklists KO “0”, filled out weekly by patients were examined. For 10 selected symp-
toms, differential treatment-induced improvement rates were searched for.
Results: Particular symptoms disappeared with different velocity during intensive psychotherapy. In sub-
groups of patients with different psychotherapy outcomes, during subsequent 9 weeks of treatment, dif-
ferent rates of selected 10 neurotic disorders’ symptoms improvement were found.
Conclusion: During psychotherapy processes with beneficial final results, a higher improvement speed 
for selected symptoms was observed. However, significant differences in particular symptom improvement 
rates make treatment monitoring more complicated.
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INTRODUCTION
Variations of symptom intensity are phenome-
na frequently observed during psychotherapy 
and well known to clinicians. However, some 
psychotherapy researchers (e.g. Lambert, Tang, 
Martinovich) focused on them only in the very 
last decades. They analyse courses of particular 
symptom change during treatment. Such stud-
ies are based mainly on frequent measurements 
of symptoms occurrence with symptom check-
lists filled by patients. A broader review of rele-
vant literature is presented in a separate publi-
cation [1].
AIM Of THe STUDY
The aim of this study was an analysis of change 
of ICD–10 neurotic disorder symptoms occur-
rence during intensive complex psychotherapy 
(group therapy with elements of individual ther-
apy) and relation of those changes to the treat-
ment outcome.
MATeRIAL AND MeTHODS
Material for analysis was a set of 3509 symptom 
checklists, filled-in in by 319 patients treated at 
the	day-hospital	of	the	Wojewódzki	Ośrodek	
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Leczenia Nerwic in Cracow, Poland in 1990–
1998. The sample consisted of 235 women and 
84 men, including 103 patients with somatoform 
disorders (F45), mostly somatization disorders 
(F45.0) without hypochondria (F45.2), 82 patients 
with diagnosis of “other anxiety disorders” (F41), 
mostly generalised anxiety disorders (F41.1) 
without panic disorders (F41.0), and 3 patients 
suffering from conversion disorders (F44), most-
ly dissociative motor disorders (F44.4) and dis-
sociative sensory disorders (F44.), 71 patients 
with a diagnosis combined of elements of anxie-
ty, conversion and somatoform disorders. In all 
the patients, the GSI value of symptom checklists 
KO “0” filled at intake, was above 15 points in 
men and above 200 points in women. Complete 
documentation of symptom intensity in subse-
quent weeks was accessible. Patients’ age was be-
tween 18–5 years (mean = 35.8 years, median 
= 3, standard deviation = 8.1).
The subject of analysis was data from symp-
tom checklists KO “0”, filled out by patients be-
fore treatment (at initial interview), on the day 
of admission to the ward, every week (on Mon-
days) and on the day of therapy completion.
The symptom checklists filled out during in-
take examination and at outcome served only 
to assess treatment effects, others pictured the 
course of symptom change along intensive psy-
chotherapy based on an integrative approach.
Assessment of treatment results was limited to 
symptom change, inferred from comparison of glo-
bal symptom level (GSL) at pre- and post- thera-
py according to the rules described earlier [2]. In 
this paper, symptom change was categorized dif-
ferently to clinical everyday practice [2], assuming 
as “symptom improvement” – result between <0.1 
and 1> (i.e. “major improvement”), as “no symp-
tom change” – result between <–0.1 and 0.1> 
(including clinical everyday category of “non-
changed” as well as “minor improvement” and 
“minor deterioration”), and as “symptom deteri-
oration” a result between <–1 and –0.1> (“major 
deterioration”). “Improvement” with outcome be-
low 100 points (for women), and below 82 points 
(for men), was considered as “symptom cured” 
(enhancing two times the clinical criteria resulting 
from the “cut-off point” of GSL “O” [3]).
Setting these criteria, 319 patients whose ques-
tionnaires were analysed, fell into three groups : 
A – improvement with disappearance of symp-
toms (129 cases – 40.4%), B – improvement with-
out full symptom remission (100 cases – 31.3%) 
and C – “no symptom changes” (87 cases – 
27.3%). Group C consisted of patients with re-
sults indicating, according to clinical criteria, mi-
nor improvement (n=59), no change (n=23) and 
minor deterioration (n=5). Two patients with an 
initial low intensity of symptoms who complet-
ed therapy with insignificant changes of global 
symptom level (GSL) and simultaneously ac-
quired the category of “symptom cure” were ex-
cluded from further analyses. The only case of 
“major deterioration” was also omitted.
Frequencies of symptoms reported by the pa-
tients in the first (intake) questionnaire were an-
alysed and in the next step, 10 symptoms (dis-
satisfaction with sexual life, lowered mood, ob-
sessive thoughts, words and imaginations, prob-
lems with falling asleep, hypochondriac fear, 
dryness in mouth, free-floating anxiety, inter-
nal tension, uneasiness, muscular tremor) were 
chosen – symptoms most frequent in 8 scales of 
the checklist [4], and 2 symptoms of commonly 
respected importance in the domain of neurot-
ic disorders: uneasiness (item 4 in the checklist 
KO “0”) and non-directed anxiety (item 4). Sep-
arately for each group (A, B and C), For each of 
those 10 symptoms, rates of patients reporting 
a particular symptom in question, were calculat-
ed in the 10 subsequent weeks (only occurrence 
of a particular symptom was calculated, its inten-
sity was omitted). Significance of differences be-
tween paired rates was statistically tested with 
two-tailed test for fractions (Statistica).
ReSULTS
Dissatisfaction with sexual life
In all the groups the symptom, “dissatisfaction 
with sexual life”, was present at the first day of 
treatment with a similar frequency. A significant 
decrease of that symptom occurred first in group 
A (at the beginning of the second week of ther-
apy, ), in group B later (); however group 
C reported significant fluctuations of frequency 
(). After the 9th week of therapy, dissatis-
faction with sexual life was found in 21% of pa-
tients from group A, in 41% in group B, and in 
40% in group C (Table 1).
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Occurrence of lowered mood
Larger differences between groups A vs. B and 
C were observed for frequency of “occurrence 
of lowered mood”. – It decreased significantly 
in group A just after 1 week of therapy while in 
group B, after the 5th week, and in the group C, 
finally after the 9th week.
In all three groups, lowered mood was present 
in almost every patient (97–99%) on the first day 
of therapy. A significant decrease of occurrence 
of that symptom happened very early in group 
A (), markedly later in group B (), but in 
group C only by the end of therapy (). It ap-
pears striking, that the difference between fre-
quency of that symptom on the first day in a day 
hospital and its occurrence at the beginning of 
the 10th week of treatment was (statistically sig-
nificant) many times larger in group A (51%) 
than in groups B (11%) and C (11%), where it 
was still reported by many patients (8–88%). In 
the group A, lowered mood was present after 
9 weeks of therapy in less than 50% of patients 
(Table 2).
Table1. Frequency of occurrence of dissatisfaction with sexual life and therapy results in the global symptom level domain
Therapy 
results
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
66%

45%

43% 40% 37%
*
36% 31%
++ *
28%
++ *
25%
++*
21%
** ++
Group 
B (n=100)
65%

55% 49%

51% 53%
*
46% 45%
*
41%
*
39%
*
41%
**
Group 
C (n=87)
59%

52% 44%

48% 46% 43%

49%
++
49%
++
45%
++
40%
++
Rates significantly lower than the rate from the first measurement were marked with <0.001; <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with *, p<0.01 ** or ++.
Table 2. Frequency of occurrence of lowered mood and therapy results in the global symptom level domain 
Therapy 
results
1st day 
of ther-
apy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
98%

88%
*
91% 91% 84%
**+
78%
**+
76%
+++**
65%
***+++
64%
***+++
47%
***+++
Group 
B (n=100)
99%

96%
*
97% 95% 97%
**
89%
+
92%
**
87%
***
85%
***
88%
***
Group 
C (n=87)
97%

94% 93% 97% 95%
+
92%
**
94%
+++
90%
+++
93%
+++
86%
+++
Rates significantly lower than the rate from the first measurement were marked with <0.005; <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with * or +, p<0.01 **, p<0.001 *** or +++.
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Obsessive thoughts, words and imaginations
Initially occurrence of obsessive thoughts in all 
three groups was frequent (81 – 89 – 71%). A sig-
nificant decrease of frequency of these symptoms 
was observed in groups A and B at the same time 
( i ); in seven weeks group C () followed. 
In group A, after 9 weeks of therapy, obsessive 
thoughts were reported only by 2% of the pa-
tients, and the difference between incidence of that 
symptom on the first day in the day-hospital and 
after 9 weeks of therapy was significantly larger in 
group A (55%) than in B (40%). It was also much 
bigger than that of group C (14%) (Table 3).
Problems with falling asleep
On the first day in the day-hospital, sleep dis-
orders occurred with the same frequency in 
groups A and B, but were a bit more frequent 
in group C. A significant decrease of its frequen-
cy occurred a bit earlier in group A (), than in 
groups B and C ( i ). In group A, this particu-
lar symptom occurred after the 9th week of ther-
apy only in 30% of patients, while in group C its 
final level was above 0% and was significantly 
– but not very much – lower than its initial lev-
el (Table 4).
Table 3. Frequency of occurrence of obsessive thoughts, words and imaginations and therapy results in the global symptom level 
domain
Therapy 
results
1st day 
of ther-
apy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
81%

71%
*+
68%

70% 55%
**
50%
**++
46%
**++
40%
*** +
35%
***++
26%
***+++
Group 
B (n=100)
89%
*
85%
+
78%

77% 72%
**
68%
**
65%
**
55%
+
54%
++
49%
***
Group 
C (n=87)
77%
*
70%
*
71% 71% 67% 72%
++
68%
++
67%
***
64%
***
63%
+++
Rates significantly lower than the rate from the first measurement were marked with <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with * or +, p<0.01 ** or ++, p<0.001 ***.
Table 4. Frequency of occurrence of problems with falling asleep and therapy results in the global symptom level domain
Therapy 
results
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
68%

60%
*
59% 55%
*+
47%
**
43%
**
39%
**
29%
+ ***
36%
***
30%
***
Group 
B (n=100)
65%

75%
*
67% 69%
*
60% 50%

53% 43%
** +
43%
++
40%
++
Group 
C (n=87)
77%

71% 68% 70%
+
67%
**
63%
**
61%
**
64%
*** **
64%
*** ++
62%
***++
Rates significantly lower than the rate from the first measurement were marked with <0.05.
Paired rates significantly different (vertically), p<0,05, were marked with * or +, p<0,01 ** or ++, p<0,001 ***.
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frequency of incidence of hypochondriac fears.
On the first day of treatment, “hypochondriac 
fear” was reported significantly more frequent 
by patients from group B as compared to group 
A. Significant decrease of that symptom was ob-
served only in groups A and B – in the fourth – 
fifth week of therapy ( and ). In group A, hy-
pochondriac fear occurred after 9th week in ca. 
30% of patients, in group B in ca. 50% (Table 5).
Dryness in mouth
On the first day of therapy “dryness in mouth” 
was present in patients from group B insignif-
icantly more frequently than in the other two 
groups. A significant decrease of frequency of 
that symptom was observed in groups A and 
B markedly earlier (  and ) than in group 
C (). In group A, dryness in the mouth was 
present after the 9th week of treatment only in 
one third of the patients, in group B in 38%, and 
in group C in 4% of the patients (Table ).
Table 5. Frequency of occurrence of hypochondriac fear and therapy results in the global symptom level domain
Therapy re-
sults
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
66%
*
61% 62%
*
56%
**
50%
*+
44%
*+
41%
+ ***
45% 33%
***++
31%
***++
Group 
B (n=100)
78%
*
73% 76%
*+
73%
**
66%
*
60%
*
58%
+
55% 54%
++
48%
++
Group 
C (n=87)
70% 68% 61%
+
67% 67%
+
59%
+
68%
***
57% 59%
***
62%
***
Rates significantly lower than the rate from the first measurement were marked with <0.01.
Paired rates significantly different (vertically), p<0.05, were marked with * or +, p<0.01 ** or ++, p<0.001 ***.
Table 6. Frequency of occurrence of dryness in mouth and therapy results in the global symptom level domain
Therapy re-
sults
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
67%

62% 59% 59% 52%

46% 44% 43% 33%
*
33%
Group 
B (n=100)
76%

73%
**
69% 61%

57% 54% 54% 45% 44% 38%
Group 
C (n=87)
63%

54%
**
66% 60% 56% 54% 54% 51% 49%
*
46%

Rates significantly lower than the rate from the first measurement were marked with <0.01; <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with *, p<0.01 **.
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free-floating anxiety
On the first day in the day-hospital, “free-float-
ing anxiety” was observed in all the three groups 
with a similar frequency (more than 80%). A sig-
nificant decrease of occurrence of that symptom 
took place only in group A (in 4th week of ther-
apy, ) and B (in th week, ). In group A, free-
floating anxiety was present by the end of ther-
apy in 37% of the patients. As for group C – in 
subsequent measurements, especially large fluc-
tuations of frequency of that symptom were ob-
served (Table 7).
Internal tension and uneasiness
Internal tension and uneasiness are symptoms 
whose frequency of occurrence was decreasing 
much later than that of the seven symptoms de-
scribed above.
On the first day of treatment, symptom of 
tension was present in almost all the patients 
(more than 97%), in all the groups. Significant 
decrease of its occurrence was observed in group 
A two weeks earlier () than in groups B () 
and C (). In that group (A), frequency of oc-
currence of tension after initial insignificant fluc-
tuations, started to decrease markedly after five 
weeks of treatment, but it was still reported after 
the ninth week of therapy by as many as ca. 70% 
Table 7. Frequency of occurrence of free-floating anxiety and therapy results in the global symptom level domain
Therapy 
results
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
82%

78%
++
77% 74%
**
67%
**++
67%
**++
52%
***+++
54%
***+++
47%
***+++
37%
***+++
Group 
B (n=100)
90%

91%
++*
87% 82% 83%
**
84%
**
77%
***
83%
***
83%
***
69%
*** *
Group 
C (n=87)
85% 79%
*
87% 90%
**
83%
++
86%
++
87%
+++
78%
+++
83%
+++
82%
+++*
Rates significantly lower than the rate from the first measurement were marked with <0.01; <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with *, p<0.01 ** or ++, p<0.001 *** or +++.
Table 8. Frequency of occurrence of tension and therapy results in the global symptom level domain 
Therapy 
results
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
97%

95%
*
95%
*
96% 92% 92% 88%
**+
84%
**+
78%
*+
71%
***++
Group 
B (n=100)
98%

100%
*
97% 98% 96% 96% 96%
+
95%
**
89%
*
87%
++
Group 
C (n=87)
99%

99% 100%
*
98% 97% 97% 98%
**
94%
+
91%
+
95%
***
Rates significantly lower than the rate from the first measurement were marked with <0.01; <0.05.
Paired rates significantly different (vertically), p<0.05, were marked with * or +, p<0.01 ** or ++, p<0.001 ***.
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of the patients. In group B, the frequency of ten-
sion increased after the first week of therapy (to 
100%), then subsequently, its step-by-step, slow 
decrease, was observed. In group C, periods of 
small fluctuations of tension and its stabilization 
(of a bit lowered incidence) occurred, only by the 
end of therapy (Table 8).
In all three groups uneasiness on the first day 
of treatment was reported by almost all the pa-
tients (97–98%). Significant decrease of frequen-
cy of incidence of that symptom took place only 
in group A and only in the second half of thera-
py (). Still, by the end of therapy, it was present 
in ca. 75% of patients. Frequency of that symp-
tom was still very high (94%) in the other two 
groups (B and C) (Table 9).
Muscle tremor
Muscle tremor was present on the first day of 
therapy, most frequently in patients from group 
B (significantly more frequent than in A). Signif-
icant decrease of frequency of occurrence of that 
symptom took place only in groups A and B – by 
the end of therapy ( and ). In group A, mus-
cular tremor was still present after the 9th week 
of therapy in 44% of patients (Table 10).
Fig.1–3 show that however a selected single 
symptom decrease is more frequent and an earli-
er phenomenon in the group of patients with the 
best results (A), in this group of subjects, symptoms 
reaction to treatment follow different patterns e.g. 
lowered mood responds earlier than tension.
Table 9. Frequency of occurrence of uneasiness and therapy results in the global symptom level domain 
Therapy re-
sults
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
97%

98% 98% 96% 95% 95% 91%

87%
*
82%
*+
76%
+++**
Group 
B (n=100)
98% 99% 99% 99% 98% 97% 94% 98%
*
95%
*
94%
+++
Group 
C (n=87)
98% 99% 98% 98% 97% 99% 95% 95% 97%
+
94%
**
Rates significantly lower than the rate from the first measurement were marked with <0.05.
Paired rates significantly different (vertically), p<0.005 were marked with * or +, p<0.001 **, p<0.001 +++.
Table 10. Frequency of occurrence of muscular tremor and therapy results in the global symptom level domain 
Therapy 
results
1 day of 
therapy
Begin-
ning 
of 2nd 
week 
Begin-
ning of 
3rd week
Begin-
ning of 
4th week
Begin-
ning of 
5th week
Begin-
ning of 
6th week
Begin-
ning of 
7th week
Begin-
ning of 
8th week
Begin-
ning of 
9th week
Begin-
ning of 
10th 
week
Group 
A (n=129)
69%
*
70%
+
74%
*
66%
*
66%
*
58%
+++*
59%
*
59% 52%
**
44%
***+++
Group 
B (n=100)
83%
*
82%
** +
85%
*+
83%
*
79%
*
72%
*
72%
*
67%

64% 69%
+++
Group 
C (n=87)
77% 64%
**
72%
+
72% 75% 80%
+++
71% 72% 72%
**
72%
***
Rates significantly lower than the rate from the first measurement were marked with <0.01.
Paired rates significantly different (vertically), p<0.05 were marked with * or +, p<0.01 **, p<0.001 *** or +++.
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DISCUSSION
In group A, frequencies of all 10 analysed symp-
toms decrease step-by-step and reach lower val-
ues earlier than in the other two groups. Occur-
rence of some symptom decrease was marked-
ly faster, e.g. dissatisfaction with sexual life and 
lowered mood as soon as in two weeks time (Ta-
bles 1 and 2) and in some it was very slowly – 
e.g. muscle tremor as late as after seven weeks of 
treatment (Table 10). In group B, the frequency 
of symptoms predominantly decreases in a slow-
er and less monotonic manner than in group A, 
and – usually from the very beginning of the stay 
in the day-hospital, it is higher than in group 
A, sometimes even higher than in group C. Fre-
quency of symptoms in that group (C) changes 
irregularly only in the late treatment, increasing 
or decreasing usually by a few percent fluctua-
tions (Tables 1–10).
Two symptoms: tension and uneasiness, very 
frequently reported by patients, disappear rath-
er late in the course of treatment and in a small 
rate of patients, but it is higher in group A, than 
in the other two groups. It seems striking, that 
even in patients who were categorized as group 
A (best results), tension and uneasiness after the 
ninth week of therapy still occurred in 70–75% of 
the group (Tables 8 and 9). Two symptoms – low-
ered mood and muscle tremor – occurred after 
the 9th week of therapy in circa half of the pa-
tients from group A (Tables 2 and 10). Simultane-
ously, they differed significantly in speed of de-
crease of incidence in the period of subsequent 
weeks – which was significantly higher for low-
ered mood. Frequency of occurrence of the re-
maining six symptoms (dissatisfaction with sex-
ual life, obsessions, problems with falling asleep, 
hypochondriac fear, dryness in mouth, and free-
floating anxiety) decreased after the ninth week 
of therapy to ca. 30% (Tables 1, 3, 4, 5,  and 7).
A generalization of the presented results of the 
analyses of most frequent symptoms decrease 
would be unjustified because of a limitation of 
this study to patients suffering from selected dis-
orders (generalized anxiety disorder, somatiza-
tion and dissociative) and the fact that, as is com-
monly known [5] symptom dynamics depend on 
the form of therapy, theoretical approach, and 
even the individual therapy programme. Fluc-
tuations of frequency of occurrence of symp-
fig. 1. Selected symptom response to treatment in patients 
with best results (group A)
fig. 2. Selected symptoms response to treatment in patients 
with medium results (group B)
fig. 3. Selected symptoms response to treatment in patients 
with worst results (group C)
 Differential response of neurotic symptoms 83
Archives of Psychiatry and Psychotherapy, 2007; 4 : 75–84
toms may be dependent also on the number of 
sessions per week and planned duration of the 
therapy [e.g. , 7, 8].
Some of the results of this study seem to be 
surprising, e.g. persisting high frequency of ten-
sion and uneasiness even in patients who com-
pleted therapy with best results (A). Also other 
symptoms, e.g. hypochondriac fear and obsessive 
thoughts, withdraw fast and in large number of 
patients from group A, despite their initially high 
incidence (and rather common view on their “re-
sistance to treatment”). Stay in a day hospital 
seems to be one of possible factors contributing 
to the removal of hypochondriac fear – contact 
with many patients with similar complaints, in-
formation from medical staff finally excluding dis-
eases, other than neurotic disorder etc. – yet such 
a connection is not expected for obsessions. Here 
it may by important to instruct and inform pa-
tients about symptoms, specific interventions (e.g. 
related to symptom), “life events” taking place in-
side and outside the ward, unfortunately the last 
information is not collected as a routine practice, 
what increases difficulties with interpretation of 
symptom dynamics [9, 10, 11, 12].
In the group of patients completing thera-
py with symptom cure (group A) especially 
the fast “disappearance” of majority of the an-
alysed symptoms may mean that those patients 
met with especially good conditions for their 
treatment (interventions adequate to their in-
dividual concept of disorder and with proper 
timing, causing insight and working-through, 
change in cognitive schemata and behaviour-
al changes). Such an assumption may be sup-
ported by e.g. the fact that decreases of inci-
dence of free-floating anxiety were visible only 
after the fourth week of treatment of that pop-
ulation (what seems discordant with the com-
mon view on special compliance of that particu-
lar symptom to non-specific therapeutic factors 
[13, 14]). Frequent decrease of free-floating anxie-
ty in the population of best therapy results may-
be because “discovering” by patients the initially 
unclear causes of that given symptom and gain-
ing hope for cure is crucial for obtaining symp-
tom cure. Why it is not happening in the case of 
tension and uneasiness – it is not known.
Easiness of decrease of lowered mood – espe-
cially fast and high in the group of symptom cure 
– may be caused by the reactivity to group influ-
ences as well as by experiencing treatment ben-
efits and “remoralisation”. It seems also connect-
ed with compliance of that particular symptom 
to treatment typical for neurotic disorders (dys-
thymia or mixed anxiety and depressive disorder, 
and not for affective disorders), with characteris-
tics of that particular symptom.
It is difficult to explain clearly why some symp-
toms respond to treating influences earlier (e.g. 
sexual dissatisfaction or lowered mood), and oth-
er later (e.g. tension, uneasiness, muscle tremor). 
A similar observation was also made by other re-
searchers [e.g. 15, 1, 17, 18, 19]. However, some 
rules in the dynamics of the analysed symptoms 
were observed. For example in the group of those 
improved and cured, rates of patients reporting 
occurrence of analysed symptoms decrease usu-
ally faster (i.e. in earlier weeks of stay) than in the 
other two groups without symptom cure. Those 
observations are consistent with literature data 
[e.g. 17, 20, 21], however in this analysis the most 
numerous differences between groups are ob-
served just after several weeks of therapy.
Description of neurotic disorders symptom dy-
namics is complicated by the differentiation of 
the process of changes of each particular single 
symptom and effect of summing and “hiding” 
their different courses. On the one hand some 
symptoms decrease generally faster, independ-
ently to final therapy effects (assessed in the do-
main of global symptom level pre- post-therapy 
change), on the other hand in groups of patients 
with different therapy results, one can observe 
different patterns of decreasing of particular 
symptoms. Because of that, global dynamics of 
symptoms in terms of GSL [5] may be complete-
ly discordant with changes of particular, single 
symptoms of different courses.
On the one hand, phenomena of symptom dy-
namics are signs of nonspecific therapeutic fac-
tors’ influences – if yes, then as it is proposed in 
literature [e.g. 22, 23], considering them as out-
come predictors seems doubtful. On the other 
hand, phenomena of symptom dynamics pro-
vide information that is interpreted in everyday 
clinical practice – they are understood and consid-
ered in the “individual context” of a particular pa-
tient, course of specific processes during psycho-
therapy, which may bring beneficial changes as 
well as failure of treatment. Then, no trait of neu-
rotic disorders symptom dynamics may serve as 
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a background to automated consideration of fur-
ther treatment as purposeless [e.g. 17, 24].
Probably analysis of dynamics of particular sin-
gle symptoms creates an opportunity to under-
stand mechanisms leading to cure or being obsta-
cles in the process of obtaining it. More thorough 
analysis of the causes of the described phenom-
ena of symptom occurrence dynamics without 
rich information on therapy sessions content is 
very difficult, if at all possible.
CONCLUSIONS
1. Particular single symptoms of the neurotic 
disorder occur during treatment with vary-
ing frequency.
2. Decrease of frequency of occurrence of se-
lected symptoms during intensive psycho-
therapy is the fastest in the group of pa-
tients completing therapy with “symptom 
cure” and slowest in the “not improved” pa-
tients.
3. The picture of a global dynamics of symp-
toms is the sum of processes of changes 
in particular single symptoms and results 
from summing and “masking” their differ-
ent courses.
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